These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4054576)

  • 21. Chronic estradiol treatment increases ovariectomized rat striatal D-1 dopamine receptors.
    Lévesque D; Di Paolo T
    Life Sci; 1989; 45(19):1813-20. PubMed ID: 2531825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of molindone and fluphenazine on the brain concentration of some phenolic and catecholic amines in the mouse and the rat.
    Juorio AV
    Br J Pharmacol; 1980 Nov; 70(3):475-80. PubMed ID: 6777007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of 17-beta-estradiol on dopamine, serotonine and GABA striatal levels in 6-hydroxydopamine-treated rats.
    Peinado V; González JC; Leret ML
    Toxicology; 2004 Nov; 204(2-3):155-60. PubMed ID: 15388241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholecystokinin attenuates basal and drug-induced increases of limbic and striatal dopamine release.
    Altar CA; Boyar WC; Oei E; Wood PL
    Brain Res; 1988 Sep; 460(1):76-82. PubMed ID: 3219572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intermittent infusion of progesterone potentiates whereas continuous infusion reduces amphetamine-stimulated dopamine release from ovariectomized estrogen-primed rat striatal fragments superfused in vitro.
    Dluzen DE; Ramirez VD
    Brain Res; 1987 Mar; 406(1-2):1-9. PubMed ID: 3567619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro progesterone modulation of amphetamine-stimulated dopamine release from the corpus striatum of ovariectomized estrogen-treated female rats: response characteristics.
    Dluzen DE; Ramirez VD
    Brain Res; 1990 May; 517(1-2):117-22. PubMed ID: 2375984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian hormones do not attenuate methamphetamine-induced dopaminergic neurotoxicity in mice gonadectomized at 4 weeks postpartum.
    Yu L; Kuo Y; Cherng CG; Chen HH; Hsu CH
    Neuroendocrinology; 2002 May; 75(5):282-7. PubMed ID: 12006781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time-course of the effects of ovarian steroids on the activity of limbic and striatal dopaminergic neurons in female rat brain.
    Fernández-Ruiz JJ; de Miguel R; Hernández ML; Ramos JA
    Pharmacol Biochem Behav; 1990 Jul; 36(3):603-6. PubMed ID: 2377660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in striatal dopamine metabolism during precipitated morphine withdrawal.
    Gramsch C; Bläsig J; Herz A
    Eur J Pharmacol; 1977 Aug; 44(3):231-40. PubMed ID: 560969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postnatal development of dopamine deamination in the striatum of the rat.
    Davis AJ; Holzbauer M; Sharman DF
    Br J Pharmacol; 1975 Dec; 55(4):558-60. PubMed ID: 1212563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 17 beta-Estradiol at a physiological dose acutely increases dopamine turnover in rat brain.
    Di Paolo T; Rouillard C; Bédard P
    Eur J Pharmacol; 1985 Nov; 117(2):197-203. PubMed ID: 4076343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of chronic estradiol and progesterone treatments of ovariectomized rats on brain dopamine uptake sites.
    Morissette M; Di Paolo T
    J Neurochem; 1993 May; 60(5):1876-83. PubMed ID: 8473903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of drugs on the formation of 3-methoxytyramine, a dopamine metabolite, in the substantia nigra, striatum, nucleus accumbens and tuberculum olfactorium of the rat.
    Westerink BH
    J Pharm Pharmacol; 1979 Feb; 31(2):94-9. PubMed ID: 33260
    [No Abstract]   [Full Text] [Related]  

  • 34. The regional distribution of p-tyramine and m-tyramine in the rat corpus striatum and the effect of monoamine oxidase inhibition.
    Sardar A; Juorio AV
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):309-13. PubMed ID: 3628835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid stimulation of striatal dopamine synthesis by estradiol.
    Pasqualini C; Olivier V; Guibert B; Frain O; Leviel V
    Cell Mol Neurobiol; 1996 Jun; 16(3):411-5. PubMed ID: 8818406
    [No Abstract]   [Full Text] [Related]  

  • 36. Time-dependent effects of estradiol and progesterone on the number of striatal dopaminergic D2-receptors.
    Fernández-Ruiz JJ; Amor JC; Ramos JA
    Brain Res; 1989 Jan; 476(2):388-95. PubMed ID: 2522808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice.
    Callier S; Morissette M; Grandbois M; Di Paolo T
    Synapse; 2000 Sep; 37(4):245-51. PubMed ID: 10891861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estradiol enhances behavioral sensitization to cocaine and amphetamine-stimulated striatal [3H]dopamine release.
    Peris J; Decambre N; Coleman-Hardee ML; Simpkins JW
    Brain Res; 1991 Dec; 566(1-2):255-64. PubMed ID: 1814541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progesterone effects upon dopamine release from the corpus striatum of female rats. I. Evidence for interneuronal control.
    Dluzen DE; Ramirez VD
    Brain Res; 1989 Jan; 476(2):332-7. PubMed ID: 2702473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The in vitro release of endogenous m-tyramine, p-tyramine and dopamine from rat striatum.
    Dyck LE; Juorio AV; Boulton AA
    Neurochem Res; 1982 Jun; 7(6):705-16. PubMed ID: 7121718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.